Thursday, September 24, 2020 11:32:29 AM
Basically, the timeline pushed another quarter but for a very good reason. Tier II Reg A! I hope 1Rivet & Adaptive close in October so we can realize 2-3 months of their revenue. XALL estimates at least $4M in 2020 revenue, based on the acquisitions already completed. 1Rivet would add at least a million in revenue this year based on $8M in below PR quote. Adaptive should add similarly. If just these two acquisitions are completed in October (remember today's PR said 2-5), we should be conservatively at $6M. IMO, it could be $7M or significantly more depending on other acquisitions and their respective sizes.
This previous article is a nice outline and worth reading again. https://emerginggrowth.com/xalles-holdings-inc-xall-growing-through-synergistic-acquisitions/
Don't forget about this one which has 2021 revenue at $34M (note that the dates in the charts yearly columns are incorrect and should be 2020 and 2021 accordingly). https://insiderfinancial.com/fintech-rollup-xalles-otcmkts-xall-shocks-street-with-acquisition-that-doubles-revenues/180210/
In my opinion; with a successful Tier II in Q1 and uplist to QB, $34M will be surpassed in Q3 2021 and possibly sooner.
GLTYA - XALL!
6/25/20 PR: The acquisition agreement defines the closing date for this transaction as on or before July 31, 2020. Details of the agreement include Xalles acquiring 100% of 1Rivet Global in exchange for 25,000,000 of Xalles’ restricted common shares. The 1Rivet Global shareholders will also be eligible for profit-sharing. 1Rivet Global has a pipeline of over $250 million and is expected to generate $8 million in revenue in the first year after the closing date.
7/21/20 PR: Adaptive is projected to generate at least $5 million in 2020 revenue and more than $10 million in revenue in 2021.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM